Alagebrium
id:
alagebrium-256-17130811
title:
Alagebrium
text:
Alagebrium was a drug candidate developed by Alteon, Inc. It was the first drug candidate to be clinically tested for the purpose of breaking the crosslinks caused by advanced glycation endproducts (AGEs), thereby reversing one of the main mechanisms of aging. Through this effect Alagebrium is designed to reverse the stiffening of blood vessel walls that contributes to hypertension and cardiovascular disease, as well as many other forms of degradation associated with protein crosslinking. Alageb
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Alagebrium
date created:
date modified:
2023-11-11T23:21:59Z
main entity:
{"identifier":"Q25717","url":"https://www.wikidata.org/entity/Q25717"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/86/Alagebrium_structure.svg","width":175,"height":124}
fields total:
13
integrity:
15